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Summary box
 ► The adequate provision of medical oxygen is going 
to make the difference between life and death for 
the majority of patients with COVID-19 in Africa.
 ► Sub- Saharan African countries lack affordable and 
reliable oxygen supply.
 ► There is evidence from sub- Saharan Africa for why 
medical oxygen provision must be made a regional 
urgent priority.
 ► Efforts being made in some African countries 
demonstrate how oxygen provision can be scaled up 
through innovative cheap technologies.
InTroduCTIon
Oxygen saves lives. Its provision is a critical 
component of emergency respiratory resusci-
tation around the world, and it consequently 
features on the WHO’s list of essential medi-
cines.1 Oxygen therapy is not just used for 
pneumonia and other lung diseases. It is also 
crucial for treating various non- respiratory 
conditions that result in hypoxaemia, such 
as sepsis, severe malaria, trauma and cardi-
ovascular diseases. It is equally essential for 
surgical care and anaesthesia.
In Western countries, the reaction to the 
COVID-19 pandemic has been to increase 
hospital capacity and to provide more inten-
sive care units (ICUs) and more ventilators. 
There had been little discussion of the provi-
sion of oxygen as this is a standard clinical 
tool widely available in hospitals. This is not 
the case in sub- Saharan Africa (SSA). There 
is a shortage of oxygen in health centres in 
SSA.2 When it comes to prioritising medical 
resources, SSA needs to save the maximum 
number of lives during the COVID-19 
pandemic; arguably, two things should be atop 
of that list before ICUs and ventilators. These 
are personal protective equipment (PPE) for 
frontline health workers and oxygen for the 
patients. The need for PPE is a global issue 
and one whose importance has been high-
lighted in the different health systems as it 
is critical to ensure frontline health workers 
are protected from COVID-19 infection and 
that they are not infection conduits within 
hospitals.
Oxygen, on the other hand, has received 
less attention, and yet it is the second most 
important aspect of the COVID-19 response. 
Critically, pneumonia is a predominant clin-
ical feature of COVID-19, and adequate venti-
lation support is essential for patient survival. 
It has been indicated that supplemental 
oxygen is a first essential step for the treat-
ment of patients with severe COVID-19 with 
hypoxaemia and should be a primary focus in 
resource- limited settings.3 In China, a study 
of 1099 hospitalised patients with laboratory- 
confirmed COVID-19 this year found that 
41.3% needed supplemental oxygen and 
2.3% needed invasive mechanical ventila-
tion.4 Therefore, investing in supplementary 
oxygen would strengthen the response to 
COVID-19 in African countries and save lives.
Prior to the COVID-19 pandemic several 
countries in SSA were already suffering from 
shortages of oxygen, shortages of equipment, 
as well as lack of training to support the 
correct and optimal use of oxygen therapy5 
especially for the treatment of paediatric 
pneumonia. For example, in 2018, only 1 
in 10 children with pneumonia in Nigeria 
received the oxygen they needed.6 In Kenya, 
many rural hospitals lack supplementary 
oxygen equipment, adequate supply chains 
for oxygen cylinders and reliable electrical 
power needed for oxygen delivery. The 
impact of such shortages during an epidemic 
were illustrated during the response to 
influenza.7 Even when available, the cost 
of oxygen in SSA can be prohibitive and 
prices fluctuate widely, often depending on 
whether or not production sites are nearby. 
For example, 6.8 m3 of oxygen (provision for 
an adult for 24 hours) can reach up to $100 
in Somalia.8
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Table 1 Comparison of oxygen cylinders and concentrators (adapted from Graham et al)22
Oxygen cylinders Oxygen concentrators
Capital cost Low (higher if including regulators and flow- meter 
assemblies)
Moderate
Running cost High: frequent refilling, transport and logistics Low: power, maintenance
Power source None required Required, continuously
Reliability Good, so long as supply lasts Good, on selected models
Continuous supply No, limited by volume (large H- type cylinders last 2–4 
days with continuous low- flow use)
Yes, limited by equipment or power failure
Maintenance Minimal: check regulators, leakage Essential: simple preventive and intermittent 
repairs
Training Yes, clinical use of oxygen, care of cylinders and 
connections
Yes, clinical use of oxygen, care of 
concentrators and connections, technical 
maintenance
need for oxygen To fIghT CoVId-19 In SSA
By modelling the epidemic in each sub- Saharan African 
country every week (see http:// tiba- partnership. org/), 
we have been able to calculate doubling times for the 
COVID-19 epidemic, providing important evidence to 
inform planning and resource mobilisation. We can calcu-
late the oxygen requirements for each country, using the 
doubling times of diseases spread and the current clinical 
knowledge available on COVID-19 to calculate a mean 
oxygen requirement per patient. On the African conti-
nent, the COVID-19 pandemic has doubled in size in 10 
days up to 16 April.9 With only two countries in Africa, 
Ethiopia10 and Nigeria11 12 having oxygen policy road-
maps, other African countries and their global partners 
need to put together a rapid plan to supply oxygen to all 
countries in the region in order to save lives.
Although the majority of people with COVID-19 have 
uncomplicated or mild illness, WHO currently esti-
mates that around 14% of cases may be severe and that 
an additional 5% will be critical and require treatment 
in ICUs.13 WHO recommends the immediate supply of 
oxygen therapy as part of clinically managing all patients 
with severe acute respiratory infection and respiratory 
distress, hypoxaemia or shock.13 Whether or not these 
patients receive oxygen will be decisive for their survival. 
It has been observed in the UK that for the hospital-
ised patients with COVID-19 who require high levels of 
supplemental oxygen, it is life- saving in approximately 
80% of the cases.14 Due to the anticipated large number 
of people in SSA who will likely require oxygen and the 
great impact this will likely have on their survival, its 
provision—together with that of oximeters and oxygen- 
delivering interfaces—should be made a regional priority.
ConTexT-releVAnT SoluTIonS To oxygen Supply
WHO indicates fewer than 2000 working ventilators exist 
in 41 African countries to serve hundreds of millions of 
people in public hospitals, compared with more than 
170 000 in the USA.15 Ten countries in Africa have no 
ventilators at all.15 Ventilators are not going to be the 
solution for the majority of patients with COVID-19 in 
Africa for two reasons. First, only a small number (<3%) 
of patients with COVID-19 need ventilators.4 Second, if 
there is no oxygen to put in the ventilators, they cannot 
be used. Allocating resources to widespread oxygen 
provision will save more lives.
Medical oxygen is a regulated commodity that must 
be at least 82% pure, free from any contamination and 
generated by an oil- free compressor.16 It can come from 
oxygen plants, liquid oxygen storage tanks or oxygen 
concentrators. In SSA, there are two main sources of 
oxygen: concentrators and cylinders (see table 1). While 
concentrators are the cheapest and most scalable way to 
supply oxygen, they require a functioning infrastructure 
with reliable power supply (although some countries 
have solved this problem by using solar- powered concen-
trators as detailed further), as well as regular servicing. 
In addition, the level of oxygen flow that they can deliver 
(usually between 5 and 10 L/min) can also be insufficient 
for severe patients requiring 15 L/min, yet they may be 
used to ease demand on cylinders, which can be directed 
to patients with severe COVID-19. The more expensive 
cylinders require neither a power source nor costly main-
tenance. Clinicians in some SSA health systems have 
indicated that the priority list would include first pulse 
oximeters to measure oxygen levels, followed by oxygen 
concentrators that can be used in small healthcare settings 
and finally higher- tech equipment like ventilators.
Some SoluTIonS from AfrICAn CounTrIeS for buIldIng 
oxygen Supply
The problem is not insurmountable. Home- grown inno-
vation is allowing some African countries to address 
the oxygen supply challenges. For example, a 42- bed 
hospital in the Gambia has managed to ensure uninter-
rupted oxygen supply for 8 years straight, using oxygen 
concentrators (rather than the more expensive cylin-
ders).17 In Kenya, a county government enabled the 
construction of an oxygen plant by a private company, 
while the hospital commissioning the plant committed 
 o
n
 June 15, 2020 at BVA. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2020-002786 on 11 June 2020. Downloaded from 
Stein F, et al. BMJ Global Health 2020;5:e002786. doi:10.1136/bmjgh-2020-002786 3
BMJ Global Health
in advanced to buying a fixed oxygen quota.18 In Ethi-
opia, a garment manufacturer that produces oxygen 
for bleaching purposes aims to provide it to a nearby 
hospital, reflecting technology spillover.15 In Uganda, 
solar- powered oxygen delivery for rural settings has 
been developed to overcome issues of unreliable power 
supply.19 Solar- powered systems can turn ambient air into 
medical- grade oxygen with battery banks, enabling unin-
terrupted service through the night and on cloudy days. 
Provided they come with ‘roadmaps’ for local procure-
ment, training and maintenance, they can be used in off- 
grid settings.20 To deal with the shortage of ventilators, 
Senegal is pioneering the use of 3- D printed ventilators 
costing ~US$60.21 These initiatives clearly demonstrate 
the successes of partnerships between governments, the 
private sector and hospitals to urgently increase regional 
oxygen availability. Development partners should be 
prioritising support for these local initiatives whose long- 
term impact and health legacy will outlast the COVID-19 
pandemic.
ConCluSIon
The recovery of critically ill patients with COVID-19 
will require oxygen. Available evidence supports prior-
itising investment in oxygen infrastructure, not only for 
COVID-19 and severe acute respiratory infections but 
also for other conditions that cause hypoxaemia. African 
countries should develop oxygen roadmaps that priori-
tise procurement of equipment, such as oxygen concen-
trators or high- pressure cylinders and oxygen from local 
industry. Examples from African countries demonstrate 
that oxygen provision can be scaled up through innova-
tive cheap technologies. Responses by development part-
ners and funders for local, context- specific solutions to 
the region’s oxygen supply shortages are encouraging. 
They need to be accelerated.
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